Aequi Acquisition said its underwriters intend to fully exercise their over-allotment option today for the purchase of $30 million in stock. In addition, Aequi said it expects to close the sale of an additional 400,000 private placement warrants at $1.50 each, generating $600,000. Shares in the data-centric SPAC trade on the Nasdaq under “ARBGU”. Read more.
Related Posts
SPACs and Listed Plays: Investors Need More Than Luck to Back the Right Managers in Asia
VERTEX Technology Acquisition's Singapore listing was small, but heavily subscribed, suggesting investors like both the Singapore framework and the SPAC's management.
Waldencast Acquisition Files Supplements to Investor Presentation on Milk and Obagi Deals
The approximately $1.2 billion merger transaction is a first step in Waldencast’s strategy to create a global multi-brand beauty and wellness platform.
BioPlus Acquisition Files Investor Presentation on $195M Avertix Medical Deal
Avertix is a medical implant company focused on improving long-term management and outcomes of high-risk coronary disease in patients who have survived one or more heart attacks.
Tracking deSPAC Performance Through a Tumultuous Market
Aftermarket performance is suffering among SPAC combinations initiated amid the elevated valuation climate of the past two years.